ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
PhoreMost, Oxford Biomedica Announce Gene Therapy Discovery Collaboration
November 18, 2020PhoreMost and Oxford Biomedica have entered into a discovery collaboration to develop next-generation CAR-T cell therapies. Financial details of the agreement are not disclosed. -
Oxford Biomedica to license LentiVector to Juno
March 19, 2020Oxford Biomedica has signed a Licence and Clinical Supply Agreement (LSA) with Bristol-Myers Squibb’s Juno Theraputics, granting the latter a non-exclusive license to the LentiVector platform.
Pharma Sources Insight January 2025
